Trial Profile
OPEN-LABEL, MULTICENTRE, RANDOMIZED CLINICAL TRIAL TO COMPARE THE PHARMACOKINETICS OF ENVARSUS TABLETS AND ADVAGRAF CAPSULES ADMINISTERED ONCE DAILY IN ADULT DE-NOVO KIDNEY TRANSPLANT PATIENTS
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- Sponsors Chiesi Farmaceutici
- 12 Sep 2021 Data from this study was used to predict the initial doses of the once-daily prolonged release tacrolimus Envarsus (LCPT) in adult kidney recipients by POPPK model, published in the Advances in Therapy
- 14 Dec 2018 Results published in the Advances in Therapy
- 03 Oct 2016 Status changed from recruiting to completed.